Angiodynamics (ANGO) Gains from Investment Securities (2014 - 2023)
Angiodynamics (ANGO) posted Gains from Investment Securities of $236000.0 for Q2 2023, up 3.96% on a QoQ basis from $227000.0 in Q1 2023, and up 14.01% year-over-year from $207000.0 in Q2 2022.
Angiodynamics (ANGO) Gains from Investment Securities (2014 - 2023) Analysis & Trends
Angiodynamics' Gains from Investment Securities history runs 10 years deep, the most recent figure standing at $236000.0 for Q2 2023.
- Quarterly Gains from Investment Securities rose 14.01% year-over-year to $236000.0 in Q2 2023, while the trailing twelve-month figure through May 2023 was $2.3 million (up 91.42% YoY) and the FY2025 annual result came in at $272000.0, down 37.04% from the prior year.
- Gains from Investment Securities was $236000.0 for Q2 2023 at Angiodynamics, up from $227000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.6 million in Q4 2022 and bottomed at -$7.6 million in Q2 2019.
- A 5-year average of -$256611.1 and a median of $204000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 1864.52% in 2019, while the deepest fall reached 3833.33% in 2019.
- Angiodynamics' Gains from Investment Securities stood at $145000.0 in 2019, then increased by 26.9% to $184000.0 in 2020, then jumped by 230.98% to $609000.0 in 2021, then surged by 170.28% to $1.6 million in 2022, then slumped by 85.66% to $236000.0 in 2023.
- Business Quant data shows ANGO's Gains from Investment Securities at $236000.0 in Q2 2023, $227000.0 in Q1 2023, and $1.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.56 Bn | 120.35 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 33.08 Bn | 31.43 Bn | 1.53 Bn |
| 4 | Medline | 32.76 Bn | 30.53 Bn | 1.84 Bn |
| 5 | Resmed | 29.25 Bn | 27.59 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.67 Bn | 23.24 Bn | 329.20 Mn |
| 7 | Solventum | 13.99 Bn | 13.43 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Angiodynamics | 573.47 Mn | 519.61 Mn | 46.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | 236,000.00 |
| May 31, 2023 | 236,000.00 |
| Feb 28, 2023 | 227,000.00 |
| Feb 28, 2023 | 227,000.00 |
| Nov 30, 2022 | 1.65 Mn |
| Nov 30, 2022 | 1.65 Mn |
| Aug 31, 2022 | 211,000.00 |
| Aug 31, 2022 | 211,000.00 |
| May 31, 2022 | 207,000.00 |
| May 31, 2022 | 207,000.00 |
| Feb 28, 2022 | 201,000.00 |
| Feb 28, 2022 | 201,000.00 |
| Nov 30, 2021 | 609,000.00 |
| Nov 30, 2021 | 609,000.00 |
| Aug 31, 2021 | 195,000.00 |
| Aug 31, 2021 | 195,000.00 |
| May 31, 2021 | 379,000.00 |
| May 31, 2021 | 379,000.00 |
| Feb 28, 2021 | 183,000.00 |
| Feb 28, 2021 | 183,000.00 |